#biotech

[ follow ]
#bankruptcy
US news
fromwww.npr.org
1 month ago

23andMe is filing for bankruptcy. Here's what it means for your genetic data

23andMe has filed for bankruptcy amidst financial struggles and concerns over user data privacy.
NYC startup
fromSilicon Canals
2 months ago

Amsterdam's biotech firm Photanol files for bankruptcy

Photanol BV has filed for bankruptcy due to financing challenges, halting its promising CO2-to-chemical technology.
NYC startup
fromSFGATE
1 month ago

Bay Area tech CEO resigns to bid for own flailing company

23andMe declared bankruptcy in Missouri court, reflecting its financial turmoil and struggles to maintain operations after a major data breach.
fromSFGATE
1 day ago
NYC startup

Bay Area biotech company, after raising $392M, forced into bankruptcy

US news
fromwww.npr.org
1 month ago

23andMe is filing for bankruptcy. Here's what it means for your genetic data

23andMe has filed for bankruptcy amidst financial struggles and concerns over user data privacy.
NYC startup
fromSilicon Canals
2 months ago

Amsterdam's biotech firm Photanol files for bankruptcy

Photanol BV has filed for bankruptcy due to financing challenges, halting its promising CO2-to-chemical technology.
NYC startup
fromSFGATE
1 month ago

Bay Area tech CEO resigns to bid for own flailing company

23andMe declared bankruptcy in Missouri court, reflecting its financial turmoil and struggles to maintain operations after a major data breach.
fromSFGATE
1 day ago
NYC startup

Bay Area biotech company, after raising $392M, forced into bankruptcy

more#bankruptcy
#theranos
NYC startup
fromNew York Post
1 week ago

Theranos felon Elizabeth Holmes advising baby-daddy on new blood-testing startup from behind bars: report

Elizabeth Holmes supports her partner's new biotech startup while serving time for fraud related to Theranos.
fromTechCrunch
1 week ago
NYC startup

Elizabeth Holmes' partner reportedly fundraising for new blood-testing startup | TechCrunch

NYC startup
fromNew York Post
1 week ago

Theranos felon Elizabeth Holmes advising baby-daddy on new blood-testing startup from behind bars: report

Elizabeth Holmes supports her partner's new biotech startup while serving time for fraud related to Theranos.
fromTechCrunch
1 week ago
NYC startup

Elizabeth Holmes' partner reportedly fundraising for new blood-testing startup | TechCrunch

more#theranos
#layoffs
Startup companies
fromSFGATE
2 months ago

Bay Area biotech company once worth $2B guts staff, departing execs get $600K

Sutro Biopharma faces drastic staff reductions and shifts in leadership due to ongoing financial losses.
fromSFGATE
2 months ago
NYC startup

Bay Area biotech company, once worth $1.2 billion, lays off almost entire staff

fromSFGATE
1 month ago
Silicon Valley

Bay Area biotech company lays off staff over sudden Trump administration order

Startup companies
fromSFGATE
2 months ago

Bay Area biotech company once worth $2B guts staff, departing execs get $600K

Sutro Biopharma faces drastic staff reductions and shifts in leadership due to ongoing financial losses.
fromSFGATE
2 months ago
NYC startup

Bay Area biotech company, once worth $1.2 billion, lays off almost entire staff

fromSFGATE
1 month ago
Silicon Valley

Bay Area biotech company lays off staff over sudden Trump administration order

more#layoffs
#fda
fromFast Company
1 month ago
Marketing tech

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views

fromFast Company
1 month ago
Marketing tech

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views

more#fda
#clinical-trials
fromSFGATE
1 month ago
Startup companies

SF biotech company, once worth nearly $1 billion, plans to shut down

fromSFGATE
1 month ago
Startup companies

SF biotech company, once worth nearly $1 billion, plans to shut down

more#clinical-trials
#funding
Venture
fromTechCrunch
2 months ago

NIH funding uncertainty spurs new biotech venture fund | TechCrunch

The Trump administration's funding restrictions could limit grants to biotech startups, prompting the launch of a new pre-seed venture fund.
Startup companies
fromMedCity News
2 months ago

How Can Startups Navigate the Difficult Funding Environment - MedCity News

The current funding environment is challenging for startups and investors, forcing a need for creative capital solutions.
European startups
fromSilicon Canals
2 months ago

Barcelona's Zymvol secures 3M: CEO Maria Fatima Lucas on democratising enzyme development, market expansion, and more - Silicon Canals

Zymvol secured €3M in seed funding to enhance its enzyme engineering technology and expand its market presence.
Miscellaneous
fromTNW | Ecosystems
4 months ago

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

Verdiva has raised $410 million to develop oral drugs for obesity, challenging established players by addressing unmet medical needs in weight loss.
fromTechCrunch
7 months ago
OMG science

French biotech Generare speeds up hunt for new drugs by cloning natural molecules | TechCrunch

Venture
fromTechCrunch
2 months ago

NIH funding uncertainty spurs new biotech venture fund | TechCrunch

The Trump administration's funding restrictions could limit grants to biotech startups, prompting the launch of a new pre-seed venture fund.
Startup companies
fromMedCity News
2 months ago

How Can Startups Navigate the Difficult Funding Environment - MedCity News

The current funding environment is challenging for startups and investors, forcing a need for creative capital solutions.
European startups
fromSilicon Canals
2 months ago

Barcelona's Zymvol secures 3M: CEO Maria Fatima Lucas on democratising enzyme development, market expansion, and more - Silicon Canals

Zymvol secured €3M in seed funding to enhance its enzyme engineering technology and expand its market presence.
Miscellaneous
fromTNW | Ecosystems
4 months ago

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

Verdiva has raised $410 million to develop oral drugs for obesity, challenging established players by addressing unmet medical needs in weight loss.
fromTechCrunch
7 months ago
OMG science

French biotech Generare speeds up hunt for new drugs by cloning natural molecules | TechCrunch

more#funding
fromSilicon Canals
1 month ago

Luxembourg's Exobiosphere raises 2M to accelerate drug discovery in space; here's why and how - Silicon Canals

Luxembourg-based Exobiosphere has raised €2M for its mission to redefine drug discovery in space using autonomous, standardised lab automation to improve efficacy.
OMG science
fromsfist.com
1 month ago

April Fool's Day Around the Bay: Bob Lee's Family Has Sued His Convicted Killer Nima Momeni

Oakland's Grand Lake Theater has been recognized as one of the 21 Coolest Movie Theaters in the World by Variety, celebrating its nostalgic charm and traditional operations.
Silicon Valley real estate
Startup companies
fromBoston.com
1 month ago

Unleased lab space. Plunging valuations. Layoffs. In Massachusetts, the biotech slump is taking its toll.

The biotech sector faces significant challenges in 2023, undermining hopes for a rebound despite scientific advancements and interest rate drops.
fromwww.theguardian.com
1 month ago

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

AstraZeneca's $2.5 billion investment in Beijing aims to strengthen its research capabilities and move beyond recent controversies by fostering collaborations with local biotech companies.
European startups
Startup companies
from24/7 Wall St.
2 months ago

Billionaire Healthcare Investor Alex Denner's Hedge Fund Has 75% of Its Assets in These 3 Stocks

Alex Denner's Sarissa Capital Management holds eight stocks, with three making up 75% of its portfolio.
Venture
fromTechCrunch
2 months ago

How automotive exec Crystal Brown founded CircNova, an AI drug discovery biotech | TechCrunch

CircNova raises $3.3 million to develop AI-driven therapies targeting circular RNA for previously untreatable conditions.
Venture
fromSFGATE
2 months ago

Bay Area biotech company that raised $66 million shuts down

Spotlight Therapeutics has closed down due to inadequate research outcomes and ongoing financial challenges.
fromwww.theguardian.com
3 months ago

Skinny jabs' are turning slimmers teetotal and drinks companies are feeling the loss

Wegovy users, like Hannah, report significant reductions in alcohol cravings and consumption, prompting analysts to predict a shift in market dynamics for the beverage industry.
Health
Health
fromNature
3 months ago

What went wrong at 23andMe? Why the genetic-data giant risks collapse

23andMe faces severe struggles, raising concerns about consumer genetic data and the future of the industry.
fromSFGATE
4 months ago

Bay Area biotech firm once worth $2.3 billion lays off 40% of staff

CytomX Therapeutics announced a significant layoff of 40% of its staff, primarily targeting general and administrative functions, to focus on clinical programs and improve cost flexibility.
Miscellaneous
from24/7 Wall St.
5 months ago

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Eli Lilly has experienced a dramatic increase of 505.84% in stock prices since 2020, transitioning from a $100 billion to a $740 billion market cap, potentially indicating a future stock split.
Business
[ Load more ]